期刊文献+

卵巢浆液性腺癌预后评分模型

Construction and verification of the prognostic model of ovarian serous adenocarcinoma
下载PDF
导出
摘要 目的:分析卵巢浆液性腺癌的预后相关因素,建立量化的预后评分模型并检验该模型的效用。方法:分别收集1995年1月—2003年12月卵巢浆液性腺癌训练样本(181例)以及1999年1月—2005年12月卵巢浆液性腺癌检验样本(42例)的临床资料进行回顾性分析。应用Kaplan-Meier单因素生存分析筛选预后相关因素,COX单因素和多因素回归分析确定各分层因素的系数,Pearson等级相关分析了解各因素之间的相关性,将风险系数转换为评分,建立卵巢浆液性腺癌预后评分模型。应用受试者工作特征(receiver operating characteristic,ROC)曲线分析判断界值,结合患者实际的3年生存情况和Ki67值,检验预后评分模型的敏感度和特异度。结果:卵巢浆液性腺癌患者的生存率与临床分期、病理分级、手术残余病灶大小、淋巴结转移情况、术后化疗情况和术前血清CA125水平等6项因素相关,其中术后化疗是相对独立的预后因素。该预后评分模型能够直观地反映COX风险比例模型的生存率。将预后评分与Ki67值进行联合判断时,其敏感度和特异度分别可达64.7%和96.0%。结论:临床分期、病理分级、手术残余病灶大小、淋巴结转移情况、术后化疗情况和术前血清标志物CA125水平是影响卵巢浆液性腺癌患者预后的主要因素。卵巢浆液性腺癌预后评分模型能够较好地反映患者的实际生存情况,预后评分与Ki67值进行联合判断可以显著提高该模型的敏感度和特异度。 Objective:To analyze the prognosis-related factors of ovarian serous adenocarcinoma in order to set up a prognostic model of serous adenocarcinoma and verify the effectiveness of the model as prognostic clinical criteria.Methods:The clinical,patholo-gical and follow-up data from 181 training samples with ovarian serous adenocarcinoma in Peking University First Hospital during January 1995 to December 2003 and another 42 detection samples with ovarian serous adenocarcinoma in Beijing Cancer Hospital during January 1999 to December 2005 were analyzed retrospectively. Kaplan-Meier univariate analysis was used to screen out prognostic factors; COX univariate and multivariate analyses were used to determine the risk coefficient of each factor and different layers in each factor; Pearson rank correlation analysis was used to identify the correlation of each factor. The prognostic model of ovarian serous adenocarcinoma was established on the conversion of risk coefficient to prognostic score and receiver operating characteristic (ROC) analysis was used to determine the cut-off value. The clinical data were collected to verify the sensitivity and specificity of the prognostic model based on the 3-year survival rate and Ki67 value.Results:The survival rate of patients with ovarian serous adenocarcinoma correlated with 6 factors including FIGO stage,histological grade,residual size,metastasis of lymph nodes,general condition after chemotherapy,and serum CA125 levels. The postoperative chemotherapy was an independent factor for prognosis. The prognostic model directly reflected the survival probability of classical COX risk ratio model,with higher score indicating lower survival probability and poorer prognosis. If combining prognostic score with Ki67 the sensitivity and specificity reached 64.7% and 96.0%,respectively.Conclusion:FIGO stage,histological grade,residual size,metastasis of lymph nodes,postoperative chemotherapy and serum CA125 were the prognostic factors of patients with ovarian serous adenocarcino
出处 《肿瘤》 CAS CSCD 北大核心 2010年第2期125-129,共5页 Tumor
关键词 卵巢肿瘤 腺癌 浆液性 预后 模型 统计学 Ovarian neoplasms Adenocarcinoma, serous Prognosis Models, statistical
  • 相关文献

参考文献6

二级参考文献74

  • 1耿京,崔恒,魏丽惠,钱和年.TP、PTP及CAP化疗方案治疗上皮性卵巢癌的比较[J].中国妇产科临床杂志,2001,2(5):283-285. 被引量:2
  • 2余捷凯,郑树,唐勇,李力.An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2005,6(4):227-231. 被引量:12
  • 3杨蓉,冯捷,房祥忠,白符,成夜霞,刘晨,朱炜,李林.卵巢浆液性腺癌预后评分模型的建立及应用[J].中华妇产科杂志,2006,41(7):459-463. 被引量:10
  • 4Polverino G, Parazzini F, Stellato G, et al. Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy. Gynecol Oncol, 2005,99 : 343-347. 被引量:1
  • 5Hightower RD, Nguyen HN, Averette HE, et al. National survey of ovarian carcinoma. Ⅳ: Patterns of care and related survival for older patients. Cancer, 1994, 73:377-383. 被引量:1
  • 6Ganz PA. Does (or should) chronologic age influence the choice of cancer treatment? Oncology, 1992, 6 (2 Suppl) :45-49. 被引量:1
  • 7Markman M, Lewis JL, Saigo P, et al. Impact of age on survival of patients with ovarian cancer. Gynecol Oncol, 1993, 49: 236-239. 被引量:1
  • 8McGuire V, Jesser CA, Whittemore AS. Survival among U. S. women with invasive epithelial ovarian cancer. Gynecol Oncol, 2002, 84:399-403. 被引量:1
  • 9De Laurentiis M, De Placido S, Bianeo AR, et al. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res, 1999, 5: 4133-4139. 被引量:1
  • 10Hoskins WJ, Bundy BN, Thigpen JT, et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage Ⅲ epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol, 1992,47:159-166. 被引量:1

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部